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Abstract: A literature review of 
individuals living with or contracting 
Lyme disease during pregnancy does 
not support an association with 
congenital anomalies or adverse 
pregnancy outcomes provided the 
patient receives adequate treatment.  
Currently, the treatment of Lyme 
disease in pregnant women should not 
differ from non-pregnant women 
except tetracyclines, such as 
doxycycline, are contraindicated and 
should not be prescribed.  
 
 
Case Presentation 
 
A 20 year old female, G1P0, at 36 
weeks gestation was admitted for 
evaluation of possible Lyme disease. 
On admission, she complained of 
headache, fevers to 102F for two 
weeks, and numbness, tingling, and 
weakness in her right thumb, index, 
and middle fingers with similar 
symptoms beginning to present in her 
left hand.  She did not observe any 
dermatologic findings such as an 
erythema migrans at the site of tick 
engorgement. Her possible tick 
exposure was one month earlier and 
she was found to be positive for Lyme 
disease enzyme immunoassay 
screening exam 2 weeks after 
exposure.  Further confirmation using 
Western Blot provided a negative 
result for both IgM and IgG. The 
University of Iowa’s  Hygienic 
Laboratory’s current criteria for 
diagnosing Lyme disease is 5 of 10 
bands for IgG and 2 of 3 bands for 
IgG.  Convalescent serology was sent 
6 weeks following exposure  and 
confirmed the negative Western blot 
result suggesting that Lyme disease 
was not the likely diagnosis. 
 
Discussion 
 
Why worry about Lyme disease in a 
pregnant woman?  Maternal syphilis, 
caused by another spirochete, 
Treponema pallidum, results in 
congenital syphilis in the neonate 
which can be characterized by lesions 
of the mucosal layers, maculopapular 
rashes, condylomas, 
hepatosplenomegaly, anemia, and 
osteochondritis among other possible 
findings. 
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Fortunately, while prior case reports 
have suggested a possible association 
between gestational borreliosis and 
adverse pregnancy outcome; no 
specific pattern of teratogenicity has 
been demonstrated, and a causal 
relationship has never been proven."1 
  
BACKGROUND ON LYME DISEASE 
 
Lyme disease was first identified by 
Steere, AC et al in 1975 and described 
as “Lyme Arthritis” after the county in 
eastern Connecticut where the 
disease was epidemic.2 It has since 
been further described, its etiologic 
agent – Borellia burgdorferi – 
identified, and classical clinical 
presentation delineated. 
  
Clinical presentation - these symptoms 
may overlap or progression of disease 
may occur in the absence of some of 
the earlier signs and symptoms. 
 
1.) Early localized disease: 
erythema migrans (EM) is a 
classical early presentation 
following a recent tick bite (<1 
month).  Constitutional 
symptoms such as myalgias, 
arthralgias, headache, and 
fatigue may accompany. 
2.) Early disseminated disease: 
multiple EM lesions (occurring 
days to weeks after infection), 
neurologic and or cardiac 
manifestations (weeks to 
months after infection). 
3.) Late Lyme disease: intermittent 
or persistent arthritis involving 
primarily large joints, neurologic 
findings such as an 
encephalopathy or 
polyneuropathy (typically 
several months to a few years 
after initial infection). 
 
LYME DISEASE ASSOCIATED WITH 
PREGNANCY 
  
Lyme disease occurring during a 
pregnancy poses no risk for fetal 
demise nor does it increase the 
frequency of congenital anomalies if 
the mother has been adequately 
treated.  Additionally, if a mother has 
been previously diagnosed and treated 
for Lyme disease there is no increased 
risk for fetal manifestations. 
 
Although several initial retrospective 
case reports and small studies 
published in the past suggested 
congenital manifestations in infants 
with mothers that contracted Lyme 
disease newer prospective evidence 
does not support this association. 
 
o “In a prospective study, 2000 
women residing in an endemic 
area had Lyme serology during 
their first prenatal visit and at 
delivery.  Neither a history of a tick 
bite nor serologic evidence of Lyme 
disease during pregnancy were 
associated with fetal death, 
decrease in infant birth weight, 
premature delivery, or congenital 
malformations.”3 
o “In a prospective study of pregnant 
women with erythema migrans 
treated during pregnancy with 
ceftriaxone, 51 of 58 (88 percent) 
delivered normal term babies. 
Among the remaining seven 
pregnancies, there was one 
spontaneous abortion, five 
premature births, and one term 
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baby with a urologic defect noted at 
seven months of age.”4 
o “A retrospective, case-control study 
of 1500 children, 796 with a 
congenital heart defect, showed no 
link between congenital heart 
disease and a history of maternal 
tick bite or maternal infection within 
three months of conception or 
during pregnancy.”5 
 
Transplacental transmission of Lyme 
disease has been described in several 
case reports but due to lack of fetal 
immunologic response there has been 
little evidence to support an 
association with congenital 
anomalies.6 Similarly, transmission of 
Lyme disease to a newborn has not 
been shown to occur by breast-
feeding. 
 
Evaluation of a pregnancy that has 
been complicated by Lyme disease 
may include examination of the 
placenta to detect Borellia 
(spirochetes) within the cord vessel.  
Additionally, culture, 
immunohistochemistry staining, and 
indirect immunofluorescence may be 
of benefit in determining the presence 
of Borellia during a pregnancy. 
 
DIAGNOSIS OF LYME DISEASE 
  
The diagnosis (and treatment) of Lyme 
disease during pregnancy is the same 
as in the nongravid patient.  Although 
Lyme disease can be diagnosed on a 
clinical basis if there is evidence of 
erythema migrans, patients suspected 
of Lyme disease often undergo 
laboratory testing.  The current gold 
standard is to first perform an enzyme-
linked immunosorbent assay (ELISA) 
which has been associated with a 
sensitivity of 68-84% and a specificity 
of 83-100%.  Due to the high false 
positive rates of this test a second 
confirmatory test is then performed by  
Western Blot testing to detect 
antibodies to the organism.  Typically, 
IgM antibodies to B. burgdorferi are 
present within 2-4 weeks after the tick 
bite.  IgG antibodies appear after 6-8 
weeks but unlike the IgM antibodies, 
the IgG antibodies remain elevated 
indefinitely.7  It is important to note that 
although these tests may indicate the 
presence of antibodies to this 
organism they may not be indicative of 
active disease. 
  
TREATMENT OF LYME DISEASE IN 
PREGNANCY 
  
The optimal treatment for Lyme 
disease in pregnant women has not 
been defined and the Infectious 
Diseases Society of America has 
suggested that treatment in pregnant 
women should not differ from those of 
non-pregnant women with the 
exception of doxycycline.8  Amoxicillin 
and third generation cephalosporins 
are safe in pregnant women.  If there 
are neurologic complications as seen 
in late Lyme infection, IV ceftriaxone 
for 14-28 days should be used.  1st-
degree AV block responds to oral 
treatment while more serious 
manifestations require IV treatment.  
Treatment of women who are 
seropositive for antibodies to B. 
burgdorferi at the time of conception is 
not warranted. 
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Conclusion 
 
Given the probability for false positives 
with the screening exam and our 
patient’s negative confirmatory exam 
the literature would not support giving 
our patient antibiotics at this time.  For 
future reference, if patients are found 
to be positive for Lyme disease by 
Western Blot, amoxicillin 500 mg PO 
TID for 14 (range 14-21 days) days is 
recommended. While not first line, 
macrolides can be given in penicillin-
allergic individuals. Third generation 
cephalosporins could be substituted in 
the event of allergy.  Tetracycline and 
doxycycline are not recommended as 
they are contraindication during 
pregnancy.  
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